Adam Stern - Profile and Investment Details

Investor Profile

Adam Stern is a Investment Bank, Corporate Venture Capital based in New York City, New York, United States with a diverse investment portfolio that includes companies such as GlobeImmune, Orchestra BioMed, Armada Water Assets, Motus GI, Helocyte, Outstanding Foods, Hydrofarm, Adgero Biopharmaceuticals, Deem, BackBeat Medical, Organovo Holdings, Kintara Therapeutics, Caliber Therapeutics, PROLOR Biotech, DarioHealth, InVivo Therapeutics, Corbus Pharmaceuticals, Western Acquisition Ventures, MATINAS BIOPHARMA, Aerami Therapeutics, . Over time, Adam Stern has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Adam Stern is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Wellness, Consumer Goods, Investment Management, Android, Energy, Wholesale, Cloud Computing, Diabetes, Technology, Finance, Software, Manufacturing, Biotechnology, Market Research, Productivity Software, Nutrition, Food and Beverage, Groceries, Capital Raising, Agriculture, Consulting, Mergers and Acquisitions, Market Intelligence, Regulatory Compliance, Medical, B2B, Therapeutics, Financial Advisory, Acquisitions, Trading may find it worthwhile to explore potential connections with Adam Stern, as their portfolio suggests a familiarity and interest in this area.

Understanding Adam Stern’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.